GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Cowin Biotech Co Ltd (SHSE:688426) » Definitions » Selling, General, & Admin. Expense

Jiangsu Cowin Biotech Co (SHSE:688426) Selling, General, & Admin. Expense : ¥26.9 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Cowin Biotech Co Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Jiangsu Cowin Biotech Co's selling, general, & admin. expense for the three months ended in Mar. 2025 was ¥31.4 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥26.9 Mil.


Jiangsu Cowin Biotech Co Selling, General, & Admin. Expense Historical Data

The historical data trend for Jiangsu Cowin Biotech Co's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Cowin Biotech Co Selling, General, & Admin. Expense Chart

Jiangsu Cowin Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling, General, & Admin. Expense
Get a 7-Day Free Trial 11.98 23.12 29.21 39.66 26.19

Jiangsu Cowin Biotech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.68 -13.34 84.54 -75.69 31.38

Competitive Comparison of Jiangsu Cowin Biotech Co's Selling, General, & Admin. Expense

For the Biotechnology subindustry, Jiangsu Cowin Biotech Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Cowin Biotech Co's Selling, General, & Admin. Expense Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Cowin Biotech Co's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Jiangsu Cowin Biotech Co's Selling, General, & Admin. Expense falls into.


;
;

Jiangsu Cowin Biotech Co Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥26.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Cowin Biotech Co  (SHSE:688426) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Jiangsu Cowin Biotech Co Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Jiangsu Cowin Biotech Co's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Cowin Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Yaocheng Avenue, 4th Floor, TQB Building, Jiangsu Province, Taizhou, CHN, 225300
Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.
Executives
Yin Jian Feng Director
Zhuang Zhi Hua Directors, senior managers

Jiangsu Cowin Biotech Co Headlines

No Headlines